These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2497223)

  • 1. Effects of hypothyroidism, tri-iodothyronine and glucocorticoids on growth hormone responses to growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2.
    Edwards CA; Dieguez C; Scanlon MF
    J Endocrinol; 1989 Apr; 121(1):31-6. PubMed ID: 2497223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of endogenous cholinergic tone and alpha-adrenergic pathways on growth hormone responses to His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the dog.
    Muruais J; Peñalva A; Dieguez C; Casanueva FF
    J Endocrinol; 1993 Aug; 138(2):211-8. PubMed ID: 8228729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-induced GH secretion in the rat.
    Mallo F; Alvarez CV; Benitez L; Burguera B; Coya R; Casanueva FF; Dieguez C
    Neuroendocrinology; 1993; 57(2):247-56. PubMed ID: 8510800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization studies using perifused rat pituitary cells show that growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 stimulate growth hormone release through distinct receptor sites.
    Blake AD; Smith RG
    J Endocrinol; 1991 Apr; 129(1):11-9. PubMed ID: 1674284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH)-releasing peptide and GH releasing hormone stimulate GH release from subpopulations of somatotrophs in rats.
    Mitani M; Kaji H; Abe H; Chihara K
    J Neuroendocrinol; 1996 Nov; 8(11):825-30. PubMed ID: 8933359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism.
    Pimentel-Filho FR; Ramos-Dias JC; Ninno FB; Façanha CF; Liberman B; Lengyel AM
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):295-300. PubMed ID: 9156038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.
    Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK
    J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.
    Arvat E; di Vito L; Maccagno B; Broglio F; Boghen MF; Deghenghi R; Camanni F; Ghigo E
    Peptides; 1997; 18(6):885-91. PubMed ID: 9285939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats.
    Yagi H; Kaji H; Sato M; Okimura Y; Chihara K
    Neuroendocrinology; 1996 Feb; 63(2):198-206. PubMed ID: 9053785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1-40) by dispersed rat anterior pituitary cells.
    Dieguez C; Foord SM; Peters JR; Hall R; Scanlon MF
    Endocrinology; 1985 Mar; 116(3):1066-70. PubMed ID: 3918846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone.
    Bercu BB; Yang SW; Masuda R; Walker RF
    Endocrinology; 1992 May; 130(5):2579-86. PubMed ID: 1315249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non-GHRH-mediated responses.
    Malozowski S; Hao EH; Ren SG; Marin G; Liu L; Southers JL; Merriam GR
    J Clin Endocrinol Metab; 1991 Aug; 73(2):314-7. PubMed ID: 1856262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome.
    Micić D; Kendereski A; Popović V; Sumarac M; Zorić S; Macut D; Dieguez C; Casanueva F
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):385-90. PubMed ID: 8959075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipamorelin, the first selective growth hormone secretagogue.
    Raun K; Hansen BS; Johansen NL; Thøgersen H; Madsen K; Ankersen M; Andersen PH
    Eur J Endocrinol; 1998 Nov; 139(5):552-61. PubMed ID: 9849822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
    Cordido F; Peñalva A; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of a second generation growth hormone-releasing peptide (Ala-His-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2) in rat anterior pituitary cells.
    Akman MS; Girard M; O'Brien LF; Ho AK; Chik CL
    Endocrinology; 1993 Mar; 132(3):1286-91. PubMed ID: 8095015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone responses to growth hormone-releasing factor (1-29) in euthyroid, hypothyroid and hyperthyroid rats.
    Dieguez C; Jordan V; Harris P; Foord S; Rodriguez-Arnao MD; Gomez-Pan A; Hall R; Scanlon MF
    J Endocrinol; 1986 Apr; 109(1):53-6. PubMed ID: 2871123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
    Leal-Cerro A; Pumar A; Garcia-Garcia E; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):649-54. PubMed ID: 7828354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.
    Popovic V; Damjanovic S; Micic D; Djurovic M; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1995 Mar; 80(3):942-7. PubMed ID: 7883854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging.
    Ghigo E; Arvat E; Rizzi G; Goffi S; Grottoli S; Mucci M; Boghen MF; Camanni F
    Eur J Endocrinol; 1994 Nov; 131(5):499-503. PubMed ID: 7952160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.